opioid use disorder

FDA approves first once-monthly injection for opioid abuseSoon after FDA approved a novel device to treat opioid use disorder, FDA approved the first and only once-monthly injectable buprenorphine formulation to treat moderate to severe opioid use disorder (OUD).
How treating opioid use disorder is cost effectiveA commercial health plan analysis by axialHealthcare has interesting findings about funding opioid use disorder treatment plans.
FDA clears first opioid withdrawal deviceFDA granted a new indication to a device that can help reduce the symptoms of withdrawal from the prescription pain drugs.
FDA advisors recommend 2 opioid use disorder drugsTwo opioid use disorder drugs have been recommended for approval by FDA committees.
Study: Formularies may be key to alleviating opioid epidemicNew Yale University research offers stunning findings about drug formulary coverage and prescribing opioids.
Two opioid use disorder drug developments to watchNew physician-administered therapies on the horizon may help rein in the opioid epidemic.
The opioid pain reliever epidemicThe aim of this article is to educate ob/gyns about what not to do for acute and chronic pain, in the hope that increased awareness will help us prevent suffering and loss of life from opioid pain relievers.
Why are teens not being treated for opioid use disorders?While opioid use disorders among teens and young adults are increasing, the number of youths who receive medication to treat opioid use is decreasing, with significant inequalities among population types.
493% Increase in Opioid Use Disorder DiagnosesA new BCBS study finds that 21% of insured members filled at least one opioid script in 2015.
Insurer: No more prior auths for opioid addiction medsAs part of efforts to combat the opioid epidemic, Cigna removes prior authorization from medication-assisted treatment for opioid use disorder.